Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.559597885753527e-74,115.15567010309279,19475.31685368046,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.3882431754438757e-71,0,0,76
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.5096403433340899e-53,51.9849166062364,6322.672681596021,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'COX11', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.943798669501475e-51,0,0,61
3,Oxidative phosphorylation WP623,2.686884723286112e-29,36.99532416149627,2433.796047532574,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",3.492950140271946e-27,0,0,35
4,Nonalcoholic fatty liver disease WP4396,1.321051310879226e-27,10.71805455850682,663.3550765408314,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.2880250281072453e-25,0,0,51
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.886299849344901e-25,34.71259842519685,1936.6852820888316,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",4.591313882489022e-23,0,0,30
6,Mitochondrial CIV Assembly WP4922,7.166631673039435e-16,25.464587394411957,887.9992002174432,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX11', 'COX14', 'SMIM20']",4.6583105874756326e-14,0,0,20
7,Mitochondrial complex III assembly WP4921,2.7370520835037022e-08,34.029893924783025,592.5897424845024,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.5249290179520626e-06,0,0,9
8,Cellular Proteostasis WP4918,2.922209217396164e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",1.4245769934806301e-05,0,0,6
9,Proteasome Degradation WP183,2.3939127725719794e-05,4.923136495643756,52.382154070226605,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMA2', 'PSMB1', 'PSME1']",0.0010373622014478578,0,0,13
10,mRNA Processing WP411,3.2371276451981016e-05,3.873249328651105,40.04257748938185,"['SF3B5', 'DHX8', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.0012624797816272596,0,0,16
11,Cholesterol Biosynthesis Pathway WP197,0.00017544624739985895,11.307692307692308,97.79093408887448,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.006220366953267727,0,0,6
12,Pyrimidine metabolism WP4022,0.0003166169386209918,3.382525152564737,27.255771756386324,"['POLR3GL', 'NME2', 'NME1', 'POLE4', 'POLD4', 'POLD2', 'POLE3', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.010290050505182233,0,0,14
13,Nucleotide Excision Repair WP4753,0.002773488885667747,3.9349920415514785,23.16785284700087,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.08320466657003242,0,0,8
14,Fatty acid transporters WP5061,0.003985331907548069,9.029558541266795,49.88952705035298,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.10979827558723526,0,0,4
15,Dual hijack model of Vif in HIV infection WP3300,0.004786078679443588,16.91850431447747,90.37939192658261,"['ELOB', 'ELOC', 'RBX1']",0.10979827558723526,0,0,3
16,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.004786078679443588,16.91850431447747,90.37939192658261,"['ELOB', 'ELOC', 'RBX1']",0.10979827558723526,0,0,3
17,Mevalonate pathway WP3963,0.004786078679443588,16.91850431447747,90.37939192658261,"['HMGCS1', 'PMVK', 'ACAT2']",0.10979827558723526,0,0,3
18,Glycolysis and Gluconeogenesis WP534,0.005130599850840906,3.4800652141692603,18.34875762817042,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'DLD', 'PFKM']",0.11065507523497616,0,0,8
19,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.005390888280678325,5.646493756003842,29.49189157852169,"['EIF5', 'EIF3I', 'EIF3J', 'EIF2S1', 'EIF1']",0.11065507523497616,0,0,5
20,Computational Model of Aerobic Glycolysis WP4629,0.006216248020396619,7.523992322456814,38.22631087189059,"['LDHA', 'TPI1', 'PGK1', 'PFKM']",0.12121683639773408,0,0,4
21,Base Excision Repair WP4752,0.006973158718321934,4.236778846153846,21.038517507561625,"['POLE4', 'POLD4', 'NEIL2', 'APEX1', 'POLD2', 'POLE3']",0.1295015190545502,0,0,6
22,DNA Mismatch Repair WP531,0.007321583451876518,5.132739498733735,25.237313924285935,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2']",0.1297917066469019,0,0,5
23,7q11.23 copy number variation syndrome WP4932,0.008372029931224254,2.426775352307267,11.606924090255111,"['ATP5PB', 'CLTC', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'SQSTM1', 'DLD', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.14196050752945472,0,0,12
24,VEGFA-VEGFR2 Signaling Pathway WP3888,0.014511676673293361,1.5441768453982931,6.536194323511042,"['RPL5', 'SET', 'NOTCH4', 'CLTC', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'PSMD4', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'TPM3', 'RPS6', 'SARS', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'PTMA']",0.22702654321964108,0,0,35
25,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.014788583711964747,8.457813998082454,35.64038043318315,"['IDI1', 'HMGCS1', 'PMVK']",0.22702654321964108,0,0,3
26,Ciliary landscape WP4352,0.015135102881309405,1.800798292026362,7.546674803280621,"['NUDC', 'NDUFA5', 'TRAF3IP1', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'COPS4', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'RAB14', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.22702654321964108,0,0,20
27,Selenium Micronutrient Network WP15,0.01600743524309434,2.4067608642076728,9.951238867279773,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.23121850906691824,0,0,10
28,Translation Factors WP107,0.018708515678706943,2.65941289810722,10.58120947600618,"['EEF1B2', 'EIF5', 'EIF1AY', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF2S1', 'EIF1']",0.2454090722615839,0,0,8
29,Aflatoxin B1 metabolism WP699,0.018893140602513177,22.538314176245212,89.45358525546025,"['AKR7A2', 'AKR7A3']",0.2454090722615839,0,0,2
30,Eukaryotic Transcription Initiation WP405,0.01950687497463872,3.2266483516483517,12.703276849781064,"['GTF2A2', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.2454090722615839,0,0,6
31,Ferroptosis WP4313,0.01950687497463872,3.2266483516483517,12.703276849781064,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.2454090722615839,0,0,6
32,Unfolded protein response WP4925,0.022779181809815294,4.512859884836852,17.067221978331833,"['XBP1', 'DDIT3', 'TNFRSF10B', 'EIF2S1']",0.2776212783071239,0,0,4
33,Synaptic Vesicle Pathway WP2267,0.03636108892017496,2.4704643888354187,8.187751576212326,"['RAB3A', 'CLTC', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2']",0.42196251378055216,0,0,7
34,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.03678647556035583,2.7094615384615386,8.948335449505967,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.42196251378055216,0,0,6
35,Melanoma WP4685,0.05310797353230398,2.101178473809204,6.167858548033492,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.5331767116074662,0,0,8
36,Androgen receptor signaling pathway WP138,0.0532298839037009,1.9935901072097113,5.847469542767754,"['CCND1', 'SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'RAN']",0.5331767116074662,0,0,9
37,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.05452822076445868,4.227468839884947,12.297862845187797,"['LDHA', 'PDHA1', 'RPS6']",0.5331767116074662,0,0,3
38,RalA downstream regulated genes WP2290,0.05452822076445868,4.227468839884947,12.297862845187797,"['RAC3', 'KRAS', 'HRAS']",0.5331767116074662,0,0,3
39,Copper homeostasis WP3286,0.054684790934099094,2.418543956043956,7.028699050218263,"['CCND1', 'COX17', 'COX11', 'MT3', 'ATOX1', 'SOD1']",0.5331767116074662,0,0,6
40,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.054684790934099094,2.418543956043956,7.028699050218263,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.5331767116074662,0,0,6
41,Peroxiredoxin 2 induced ovarian failure WP4873,0.056389240367778155,7.511494252873563,21.599128301002157,"['STAR', 'BAX']",0.5363854571569141,0,0,2
42,Cytosolic DNA-sensing pathway WP4655,0.061638668257792614,2.3349469496021222,6.506249992493854,"['POLR3GL', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.5723590623937886,0,0,6
43,DNA Repair Pathways Full Network WP4946,0.06424502521680106,1.7757902001380261,4.874634641126482,"['POLE4', 'POLD4', 'NEIL2', 'CENPX', 'APEX1', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.5826874380128468,0,0,11
44,Cori Cycle WP1946,0.06842374801690049,3.757430488974113,10.077561289065141,"['LDHA', 'TPI1', 'PGK1']",0.5930058161464709,0,0,3
45,TP53 network WP1742,0.06842374801690049,3.757430488974113,10.077561289065141,"['SUMO1', 'GADD45A', 'BAX']",0.5930058161464709,0,0,3
46,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.08008757149042835,5.633141762452107,14.221624596605407,"['COX8A', 'COX5A']",0.6633409742672394,0,0,2
47,TCA cycle in senescence WP5050,0.08008757149042835,5.633141762452107,14.221624596605407,"['PDHA1', 'GOT1']",0.6633409742672394,0,0,2
48,Mitochondrial CII Assembly WP4920,0.08164196606366023,inf,inf,['SDHAF1'],0.6633409742672394,0,0,1
49,Nanomaterial induced apoptosis WP2507,0.0837396639338002,3.3813998082454457,8.386015340823647,"['ENDOG', 'BAX', 'CYCS']",0.6641845979796881,0,0,3
50,DNA damage response WP707,0.08515187153585745,1.9750240615976902,4.865114084733432,"['CCNB1', 'CCND1', 'GADD45A', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.6641845979796881,0,0,7
51,Leptin signaling pathway WP2034,0.10132367242542209,1.8806544754571703,4.305636571503336,"['CCND1', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.7599275431906657,0,0,7
52,miRNA regulation of DNA damage response WP1530,0.10132367242542209,1.8806544754571703,4.305636571503336,"['CCNB1', 'CCND1', 'GADD45A', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.7599275431906657,0,0,7
53,Trans-sulfuration pathway WP2333,0.106207191994374,4.506130268199234,10.104381819934686,"['AHCY', 'GOT1']",0.7815246203359596,0,0,2
54,Non-small cell lung cancer WP4255,0.10999348683749505,1.836761644694138,4.054346658763012,"['CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.7943974049374642,0,0,7
55,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.11818103756211815,2.8173537871524448,6.016564983272058,"['RRAS', 'KRAS', 'HRAS']",0.8290526558661812,0,0,3
56,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.11904345827822088,1.7948639426021524,3.819949082753508,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.8290526558661812,0,0,7
57,CAMKK2  Pathway WP4874,0.12734517773326587,2.254510556621881,4.646216973580735,"['FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2']",0.8713091108065559,0,0,4
58,Myometrial relaxation and contraction pathways WP289,0.13352524358320064,1.4889365953195741,2.997921317658257,"['RGS4', 'CNN1', 'GNG3', 'YWHAQ', 'PRKAR1A', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.8722715018744432,0,0,12
59,Glycolysis in senescence WP5049,0.13419561567299126,3.7547892720306515,7.5413317646500655,"['LDHA', 'PGK1']",0.8722715018744432,0,0,2
60,HIF1A and PPARG regulation of glycolysis WP2456,0.13419561567299126,3.7547892720306515,7.5413317646500655,"['LDHA', 'TPI1']",0.8722715018744432,0,0,2
61,Methionine De Novo and Salvage Pathway WP3580,0.13706226462881038,2.600413009808983,5.167852704797134,"['AHCY', 'ODC1', 'TXN']",0.8762997246760008,0,0,3
62,miRNA regulation of prostate cancer signaling pathways WP3981,0.14237814363476922,2.146970112421168,4.185021806358133,"['CCND1', 'BAD', 'KRAS', 'IKBKG']",0.8934334299261447,0,0,4
63,Pathogenic Escherichia coli infection WP2272,0.14602078541872415,1.7805668016194331,3.42582174660234,"['TUBA1A', 'YWHAQ', 'ARPC2', 'ARPC3', 'ARPC5L', 'ACTG1']",0.8934334299261447,0,0,6
64,GABA metabolism (aka GHB) WP4157,0.15662448567551976,11.258373205741627,20.87194480349676,['AKR7A2'],0.8934334299261447,0,0,1
65,GABA receptor Signaling WP4159,0.1568819489145569,2.4144637720860156,4.472218708797246,"['GABRB3', 'AP2S1', 'AP2M1']",0.8934334299261447,0,0,3
66,Photodynamic therapy-induced unfolded protein response WP3613,0.1568819489145569,2.4144637720860156,4.472218708797246,"['NARS', 'XBP1', 'DDIT3']",0.8934334299261447,0,0,3
67,Statin inhibition of cholesterol production WP430,0.1568819489145569,2.4144637720860156,4.472218708797246,"['SQLE', 'APOC1', 'FDFT1']",0.8934334299261447,0,0,3
68,Amyotrophic lateral sclerosis (ALS) WP2447,0.15806899144847175,2.049206072238702,3.7802189800274304,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.8934334299261447,0,0,4
69,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.15806899144847175,2.049206072238702,3.7802189800274304,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.8934334299261447,0,0,4
70,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.16357428537394147,3.2181171319102355,5.826362601276965,"['IDH3B', 'DLD']",0.8985066379695377,0,0,2
71,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.16357428537394147,3.2181171319102355,5.826362601276965,"['PDHA1', 'DLD']",0.8985066379695377,0,0,2
72,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.18198610722145667,1.649859287054409,2.811071382240996,"['PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMD4', 'STUB1']",0.9611402971082417,0,0,6
73,Senescence and Autophagy in Cancer WP615,0.18848866338742126,1.503660886319846,2.509185107381689,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'RNASEL', 'MAP1LC3A', 'SQSTM1', 'HRAS', 'GABARAP']",0.9611402971082417,0,0,8
74,Bladder cancer WP2828,0.19119560485328696,1.8781190019193859,3.107269506877905,"['CCND1', 'DAPK1', 'KRAS', 'HRAS']",0.9611402971082417,0,0,4
75,Metabolic reprogramming in colon cancer WP4290,0.19119560485328696,1.8781190019193859,3.107269506877905,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9611402971082417,0,0,4
76,Galanin receptor pathway WP4970,0.19393020215276394,2.8156130268199235,4.618328884669956,"['POMC', 'VAMP2']",0.9611402971082417,0,0,2
77,Homologous recombination WP186,0.19393020215276394,2.8156130268199235,4.618328884669956,"['POLD4', 'POLD2']",0.9611402971082417,0,0,2
78,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.19393020215276394,2.8156130268199235,4.618328884669956,"['RRAS', 'IKBKG']",0.9611402971082417,0,0,2
79,Endometrial cancer WP4155,0.1946925217219259,1.6104395604395605,2.635216647882647,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.9611402971082417,0,0,6
80,Canonical and non-canonical Notch signaling WP3845,0.1988312437794823,2.1122962607861937,3.411989689729055,"['RRAS', 'NOTCH4', 'DLL3']",0.9663865168213848,0,0,3
81,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.20988844611353022,1.6573430524947732,2.5874093324156195,"['BEX3', 'SERBP1', 'TNFRSF10B', 'RNF7', 'SQSTM1']",0.9663865168213848,0,0,5
82,Notch Signaling Pathway Netpath WP61,0.20988844611353022,1.6573430524947732,2.5874093324156195,"['PSENEN', 'CCND1', 'NOTCH4', 'SKP1', 'DLL3']",0.9663865168213848,0,0,5
83,Alzheimer's disease WP2059,0.21579044701883315,1.4889316650625601,2.2831985318544707,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9663865168213848,0,0,7
84,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.21579044701883315,1.4889316650625601,2.2831985318544707,"['CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.9663865168213848,0,0,7
85,Pancreatic adenocarcinoma pathway WP4263,0.2210291896321662,1.4316909808239289,2.1610809929265136,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG', 'PAK4']",0.9663865168213848,0,0,8
86,Cysteine and methionine catabolism WP4504,0.22490842644316741,2.5025542784163473,3.733966024662952,"['AHCY', 'GOT1']",0.9663865168213848,0,0,2
87,PPAR-alpha pathway WP2878,0.22490842644316741,2.5025542784163473,3.733966024662952,"['CCND1', 'DBI']",0.9663865168213848,0,0,2
88,Gastric acid production WP2596,0.22549018725832312,5.628708133971291,8.383840516477324,['CCK'],0.9663865168213848,0,0,1
89,miRNA Biogenesis WP2338,0.22549018725832312,5.628708133971291,8.383840516477324,['RAN'],0.9663865168213848,0,0,1
90,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.22549018725832312,5.628708133971291,8.383840516477324,['MAS1'],0.9663865168213848,0,0,1
91,The alternative pathway of fetal androgen synthesis WP4524,0.22549018725832312,5.628708133971291,8.383840516477324,['STAR'],0.9663865168213848,0,0,1
92,Integrated breast cancer pathway WP1984,0.23637676485816128,1.342388306674021,1.9361646250856999,"['CCND1', 'RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU', 'CCNB1IP1']",0.9824832645991202,0,0,10
93,G Protein Signaling Pathways WP35,0.24040198767940146,1.4345437046110772,2.0448600066976783,"['GNG3', 'PDE1C', 'RRAS', 'PRKAR1A', 'KRAS', 'HRAS', 'CALM2']",0.9824832645991202,0,0,7
94,MET in type 1 papillary renal cell carcinoma WP4205,0.24050287279989305,1.5650016010246557,2.2301636589735887,"['BAD', 'RPL11', 'KRAS', 'HRAS', 'PAK4']",0.9824832645991202,0,0,5
95,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.24304725280098713,1.8772770853307765,2.6554073081581864,"['BAD', 'KRAS', 'HRAS']",0.9824832645991202,0,0,3
96,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.2443612222208068,1.6690125826402218,2.3518185308160766,"['YWHAQ', 'LIMD1', 'ACTG1', 'PAK4']",0.9824832645991202,0,0,4
97,NO/cGMP/PKG mediated Neuroprotection WP4008,0.2443612222208068,1.6690125826402218,2.3518185308160766,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9824832645991202,0,0,4
98,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.25620536487652457,2.2521072796934867,3.066865529291589,"['BAD', 'BAX']",0.9991134529153675,0,0,2
99,DNA Replication WP466,0.2627728126310352,1.6092678914176035,2.1507309373515064,"['POLD4', 'POLD2', 'RPA2', 'UBA52']",0.9991134529153675,0,0,4
100,TNF-alpha signaling pathway WP231,0.2658538859864259,1.3839724431386455,1.8334983483812328,"['BAD', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.9991134529153675,0,0,7
101,Cell cycle WP179,0.26754990197470957,1.3174992798907939,1.7370558460211332,"['CDKN2D', 'CCNB1', 'CCND1', 'YWHAQ', 'GADD45A', 'SKP1', 'RBX1', 'ANAPC11', 'YWHAH']",0.9991134529153675,0,0,9
102,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.27221723254158936,1.4823803023408666,1.9288063679445866,"['IDI1', 'SQLE', 'HMGCS1', 'DBI', 'FDFT1']",0.9991134529153675,0,0,5
103,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2875627648118576,2.047196098920237,2.551449425338463,"['CD63', 'SOD1']",0.9991134529153675,0,0,2
104,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2875627648118576,2.047196098920237,2.551449425338463,"['LDHA', 'PDHA1']",0.9991134529153675,0,0,2
105,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.2875627648118576,2.047196098920237,2.551449425338463,"['KRAS', 'HRAS']",0.9991134529153675,0,0,2
106,Endothelin Pathways WP2197,0.28862182006269327,1.6892617449664429,2.09914088507405,"['CNN1', 'RIIAD1', 'CALM2']",0.9991134529153675,0,0,3
107,Glucuronidation WP698,0.2887376054961438,3.7521531100478467,4.6610632081786445,['UGP2'],0.9991134529153675,0,0,1
108,MED and Pseudoachondroplasia genes WP4789,0.2887376054961438,3.7521531100478467,4.6610632081786445,['COL9A3'],0.9991134529153675,0,0,1
109,22q11.2 copy number variation syndrome WP4657,0.30528435981983704,1.314436958614052,1.5595947112774409,"['RANBP1', 'MRPL40', 'DGCR6L', 'EMC10', 'RAN', 'RBX1', 'PAK4']",0.9991134529153675,0,0,7
110,MAPK Cascade WP422,0.31166133804664514,1.608683741953157,1.875464854624244,"['RRAS', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
111,Parkinson's disease pathway WP2371,0.31166133804664514,1.608683741953157,1.875464854624244,"['PINK1', 'CYCS', 'PARK7']",0.9991134529153675,0,0,3
112,Type 2 papillary renal cell carcinoma WP4241,0.31166133804664514,1.608683741953157,1.875464854624244,"['ELOB', 'ELOC', 'RBX1']",0.9991134529153675,0,0,3
113,Nucleotide metabolism WP404,0.3187623455962358,1.8764367816091954,2.1453479084515257,"['NME2', 'OAZ1']",0.9991134529153675,0,0,2
114,Serotonin and anxiety WP3947,0.3187623455962358,1.8764367816091954,2.1453479084515257,"['POMC', 'CRH']",0.9991134529153675,0,0,2
115,PPAR signaling pathway WP3942,0.3192750760686022,1.4531607949972138,1.659076935230804,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.9991134529153675,0,0,4
116,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.32121996750156007,1.3735620065134369,1.5598570312918825,"['BAD', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9991134529153675,0,0,5
117,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.33474540645031464,1.535431011941079,1.680352693850836,"['MAP1LC3A', 'ATG101', 'FTL']",0.9991134529153675,0,0,3
118,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.33474540645031464,1.535431011941079,1.680352693850836,"['STAR', 'CALM3', 'CALM2']",0.9991134529153675,0,0,3
119,IL-18 signaling pathway WP4754,0.3439840398480984,1.1499633801144125,1.2271949419690085,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'AARS', 'ITM2C']",0.9991134529153675,0,0,15
120,Acetylcholine Synthesis WP528,0.3468246908968101,2.8138755980861245,2.979713720825355,['PDHA1'],0.9991134529153675,0,0,1
121,Alanine and aspartate metabolism WP106,0.3468246908968101,2.8138755980861245,2.979713720825355,['GOT1'],0.9991134529153675,0,0,1
122,"Degradation pathway of sphingolipids, including diseases WP4153",0.3468246908968101,2.8138755980861245,2.979713720825355,['GM2A'],0.9991134529153675,0,0,1
123,Glial Cell Differentiation WP2276,0.3468246908968101,2.8138755980861245,2.979713720825355,['GAP43'],0.9991134529153675,0,0,1
124,let-7 inhibition of ES cell reprogramming WP3299,0.3468246908968101,2.8138755980861245,2.979713720825355,['TRIM71'],0.9991134529153675,0,0,1
125,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3468246908968101,2.8138755980861245,2.979713720825355,['MOCS2'],0.9991134529153675,0,0,1
126,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3480108259174848,1.2069844331175092,1.2739982495329027,"['GABRB3', 'RAB3A', 'BAD', 'RPS6', 'RACK1', 'IKBKG', 'SQSTM1', 'EIF2S1', 'HRAS']",0.9991134529153675,0,0,9
127,IL-7 signaling pathway WP205,0.3496210032008603,1.7319481284998526,1.8201139164859963,"['CCND1', 'BAD']",0.9991134529153675,0,0,2
128,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3496210032008603,1.7319481284998526,1.8201139164859963,"['TNFRSF10B', 'BAX']",0.9991134529153675,0,0,2
129,Acute viral myocarditis WP4298,0.3544352933709484,1.309452002770145,1.3582022185412854,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX']",0.9991134529153675,0,0,5
130,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.35746565913366896,1.3648577909614379,1.4040510197565967,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.9991134529153675,0,0,4
131,ATM Signaling Pathway WP2516,0.357790151597593,1.4685480845387469,1.5093863995102164,"['CCNB1', 'GADD45A', 'IKBKG']",0.9991134529153675,0,0,3
132,Fas ligand pathway and stress induction of heat shock proteins WP314,0.357790151597593,1.4685480845387469,1.5093863995102164,"['ARHGDIB', 'CYCS', 'ACTG1']",0.9991134529153675,0,0,3
133,Small cell lung cancer WP4658,0.37310121609030034,1.212808173539646,1.1957142964477034,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.9991134529153675,0,0,7
134,Genotoxicity pathway WP4286,0.37656933489549976,1.324602009709834,1.2936766488074534,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9991134529153675,0,0,4
135,Modulators of TCR signaling and T cell activation WP5072,0.37656933489549976,1.324602009709834,1.2936766488074534,"['NDUFB10', 'ELOB', 'IKBKG', 'RNF7']",0.9991134529153675,0,0,4
136,Prader-Willi and Angelman Syndrome WP3998,0.37656933489549976,1.324602009709834,1.2936766488074534,"['GABRB3', 'POMC', 'CCND1', 'FEZ1']",0.9991134529153675,0,0,4
137,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.37998653007979977,1.6081007115489874,1.556029564725877,"['H3F3B', 'H2AFZ']",0.9991134529153675,0,0,2
138,Glycogen Synthesis and Degradation WP500,0.38071879606013465,1.4072387344199424,1.358962346389987,"['UGP2', 'CALM3', 'CALM2']",0.9991134529153675,0,0,3
139,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.38071879606013465,1.4072387344199424,1.358962346389987,"['NDUFA13', 'COPS6', 'IKBKG']",0.9991134529153675,0,0,3
140,G1 to S cell cycle control WP45,0.38778075205401036,1.2510406660262567,1.18512980258719,"['CDKN2D', 'CCNB1', 'CCND1', 'GADD45A', 'RPA2']",0.9991134529153675,0,0,5
141,Ras signaling WP4223,0.39023230992078534,1.1366130390462261,1.069567703376638,"['GNG3', 'RASA4B', 'RRAS', 'BAD', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'PAK4']",0.9991134529153675,0,0,11
142,Exercise-induced Circadian Regulation WP410,0.3956185740951122,1.2866465588154647,1.1931134380640998,"['IDI1', 'UGP2', 'SUMO1', 'STBD1']",0.9991134529153675,0,0,4
143,Canonical NF-KB pathway WP4562,0.4001721014112409,2.250909090909091,2.0615188849957438,['IKBKG'],0.9991134529153675,0,0,1
144,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.4001721014112409,2.250909090909091,2.0615188849957438,['IKBKG'],0.9991134529153675,0,0,1
145,G13 Signaling Pathway WP524,0.4034615723980742,1.3508341323106423,1.2261170627619962,"['CFL2', 'ARHGDIB', 'CALM2']",0.9991134529153675,0,0,3
146,Histone Modifications WP2369,0.4034615723980742,1.3508341323106423,1.2261170627619962,"['SET', 'H3F3B', 'SETD9']",0.9991134529153675,0,0,3
147,Oxidative Damage WP3941,0.4034615723980742,1.3508341323106423,1.2261170627619962,"['BAD', 'GADD45A', 'CYCS']",0.9991134529153675,0,0,3
148,Amino Acid metabolism WP3925,0.4044256470269082,1.2237397151568308,1.1078361130701597,"['LDHA', 'PDHA1', 'GOT1', 'ODC1', 'DLD']",0.9991134529153675,0,0,5
149,"Relationship between inflammation, COX-2 and EGFR WP4483",0.40973379863093295,1.5007662835249043,1.3390551173130207,"['KRAS', 'HRAS']",0.9991134529153675,0,0,2
150,SARS-CoV-2 mitochondrial interactions WP5038,0.40973379863093295,1.5007662835249043,1.3390551173130207,"['NDUFB9', 'PHB']",0.9991134529153675,0,0,2
151,Striated Muscle Contraction Pathway WP383,0.40973379863093295,1.5007662835249043,1.3390551173130207,"['TPM3', 'ACTG1']",0.9991134529153675,0,0,2
152,Sleep regulation WP3591,0.4259555618672992,1.2987683457482115,1.1083952102420722,"['AHCY', 'STAR', 'CRH']",0.9991134529153675,0,0,3
153,Intraflagellar transport proteins binding to dynein WP4532,0.4387613607437317,1.4068486590038314,1.1589613781699397,"['IFT22', 'DYNLL1']",0.9991134529153675,0,0,2
154,Apoptosis Modulation and Signaling WP1772,0.4400218478996078,1.1447522816166884,0.9397625196630323,"['ENDOG', 'AIFM2', 'BAD', 'TNFRSF10B', 'CYCS', 'BAX']",0.9991134529153675,0,0,6
155,Regulation of Actin Cytoskeleton WP51,0.44322726189553735,1.1012745796821937,0.8960769879452147,"['RRAS', 'CFL2', 'TMSB4X', 'BRK1', 'RAC3', 'KRAS', 'ACTG1', 'SSH1', 'PAK4']",0.9991134529153675,0,0,9
156,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.44814447470920843,1.250559284116331,1.003748416541583,"['BANF1', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
157,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.44814447470920843,1.250559284116331,1.003748416541583,"['STAR', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
158,ACE Inhibitor Pathway WP554,0.4491662347576852,1.875598086124402,1.5011578601283722,['MAS1'],0.9991134529153675,0,0,1
159,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.4491662347576852,1.875598086124402,1.5011578601283722,['NSDHL'],0.9991134529153675,0,0,1
160,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.4491662347576852,1.875598086124402,1.5011578601283722,['STAR'],0.9991134529153675,0,0,1
161,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4491662347576852,1.875598086124402,1.5011578601283722,['RPS6'],0.9991134529153675,0,0,1
162,Insulin signaling in adipocytes (normal condition) WP3634,0.4491662347576852,1.875598086124402,1.5011578601283722,['RPS6'],0.9991134529153675,0,0,1
163,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.4491662347576852,1.875598086124402,1.5011578601283722,['SQSTM1'],0.9991134529153675,0,0,1
164,Iron metabolism in placenta WP2007,0.4491662347576852,1.875598086124402,1.5011578601283722,['FTH1'],0.9991134529153675,0,0,1
165,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.4491662347576852,1.875598086124402,1.5011578601283722,['BAX'],0.9991134529153675,0,0,1
166,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4491662347576852,1.875598086124402,1.5011578601283722,['AHCY'],0.9991134529153675,0,0,1
167,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4491662347576852,1.875598086124402,1.5011578601283722,['VEGFB'],0.9991134529153675,0,0,1
168,NLR Proteins WP288,0.4491662347576852,1.875598086124402,1.5011578601283722,['IKBKG'],0.9991134529153675,0,0,1
169,Purine metabolism WP4792,0.4491662347576852,1.875598086124402,1.5011578601283722,['APRT'],0.9991134529153675,0,0,1
170,Role of Osx and miRNAs in tooth development WP3971,0.4491662347576852,1.875598086124402,1.5011578601283722,['NOTCH4'],0.9991134529153675,0,0,1
171,Supression of HMGB1 mediated inflammation by THBD WP4479,0.4491662347576852,1.875598086124402,1.5011578601283722,['IKBKG'],0.9991134529153675,0,0,1
172,Thiamine metabolic pathways WP4297,0.4491662347576852,1.875598086124402,1.5011578601283722,['PDHA1'],0.9991134529153675,0,0,1
173,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.45203727773018987,1.1847661379937366,0.9406932119483847,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9991134529153675,0,0,4
174,Proximal tubule transport WP4917,0.45203727773018987,1.1847661379937366,0.9406932119483847,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9991134529153675,0,0,4
175,16p11.2 proximal deletion syndrome WP4949,0.45391320877047353,1.148522809700249,0.9071599020450819,"['TMEM219', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.9991134529153675,0,0,5
176,Apoptosis WP254,0.45391320877047353,1.148522809700249,0.9071599020450819,"['BAD', 'TNFRSF10B', 'CYCS', 'BAX', 'IKBKG']",0.9991134529153675,0,0,5
177,Autophagy WP4923,0.4669884214405349,1.3239801667793554,1.0081457771833784,"['MAP1LC3B', 'ATG101']",0.9991134529153675,0,0,2
178,Fatty acid beta-oxidation WP143,0.4669884214405349,1.3239801667793554,1.0081457771833784,"['TPI1', 'DLD']",0.9991134529153675,0,0,2
179,DNA damage response (only ATM dependent) WP710,0.4841309562776465,1.0890818858560793,0.7900198236140458,"['CCND1', 'BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.9991134529153675,0,0,6
180,Aryl Hydrocarbon Receptor Netpath WP2586,0.4914134348693451,1.1641154494660628,0.8270684972066712,"['AIP', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
181,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4941620160729484,1.6075187969924811,1.1331268951931062,['CCK'],0.9991134529153675,0,0,1
182,Dopamine metabolism WP2436,0.4941620160729484,1.6075187969924811,1.1331268951931062,['SOD1'],0.9991134529153675,0,0,1
183,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.4941620160729484,1.6075187969924811,1.1331268951931062,['MAP1LC3A'],0.9991134529153675,0,0,1
184,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.4941620160729484,1.6075187969924811,1.1331268951931062,['CCND1'],0.9991134529153675,0,0,1
185,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4941620160729484,1.6075187969924811,1.1331268951931062,['DLL3'],0.9991134529153675,0,0,1
186,Gastric Cancer Network 2 WP2363,0.49435214821576695,1.2503192848020435,0.8808588948211825,"['S100A6', 'COL9A3']",0.9991134529153675,0,0,2
187,Nanoparticle-mediated activation of receptor signaling WP2643,0.49435214821576695,1.2503192848020435,0.8808588948211825,"['KRAS', 'HRAS']",0.9991134529153675,0,0,2
188,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5066347512761888,1.097795047048359,0.746462150649583,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.9991134529153675,0,0,4
189,Hippo-Merlin Signaling Dysregulation WP4541,0.5087756195342107,1.0502021174205967,0.7096721754510277,"['CCND1', 'PRKAR1A', 'KRAS', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9991134529153675,0,0,7
190,IL-3 signaling pathway WP286,0.5124115083957758,1.125215723873442,0.7523498944609931,"['YWHAQ', 'BAD', 'HRAS']",0.9991134529153675,0,0,3
191,ErbB signaling pathway WP673,0.5179449205545295,1.0614793467819403,0.6983327978424259,"['CCND1', 'BAD', 'KRAS', 'HRAS', 'PAK4']",0.9991134529153675,0,0,5
192,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5208052809625932,1.1844121798749747,0.7726856903962369,"['RAB3A', 'NEFL']",0.9991134529153675,0,0,2
193,Lipid Metabolism Pathway WP3965,0.5208052809625932,1.1844121798749747,0.7726856903962369,"['PDHA1', 'PRKAR1A']",0.9991134529153675,0,0,2
194,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5208052809625932,1.1844121798749747,0.7726856903962369,"['CCND1', 'TPM3']",0.9991134529153675,0,0,2
195,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5354854587830359,1.4064593301435406,0.878448539895538,['CCND1'],0.9991134529153675,0,0,1
196,Serotonin and anxiety-related events WP3944,0.5354854587830359,1.4064593301435406,0.878448539895538,['CRH'],0.9991134529153675,0,0,1
197,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5354854587830359,1.4064593301435406,0.878448539895538,['HMGCS1'],0.9991134529153675,0,0,1
198,Sulfation Biotransformation Reaction WP692,0.5354854587830359,1.4064593301435406,0.878448539895538,['SULT4A1'],0.9991134529153675,0,0,1
199,Glycosylation and related congenital defects WP4521,0.5463140124181023,1.125095785440613,0.6801894316880687,"['DPM2', 'DPM3']",0.9991134529153675,0,0,2
200,Kit receptor signaling pathway WP304,0.5529709650329401,1.0547099712368169,0.6248626939030099,"['BAD', 'RPS6', 'HRAS']",0.9991134529153675,0,0,3
201,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5529709650329401,1.0547099712368169,0.6248626939030099,"['TKFC', 'PIN1', 'IKBKG']",0.9991134529153675,0,0,3
202,Aryl Hydrocarbon Receptor Pathway WP2873,0.5708561100310277,1.0714285714285714,0.6006622473488565,"['AIP', 'BAX']",0.9991134529153675,0,0,2
203,IL-2 signaling pathway WP49,0.5708561100310277,1.0714285714285714,0.6006622473488565,"['RPS6', 'HRAS']",0.9991134529153675,0,0,2
204,Folate Metabolism WP176,0.5724817762106003,1.0226619018565328,0.5704146041740974,"['AHCY', 'GPX4', 'SOD1']",0.9991134529153675,0,0,3
205,Biomarkers for urea cycle disorders WP4583,0.5734360175940056,1.250079744816587,0.6951804885841268,['GOT1'],0.9991134529153675,0,0,1
206,Glutathione metabolism WP100,0.5734360175940056,1.250079744816587,0.6951804885841268,['GPX4'],0.9991134529153675,0,0,1
207,Nanoparticle triggered autophagic cell death WP2509,0.5734360175940056,1.250079744816587,0.6951804885841268,['MAP1LC3A'],0.9991134529153675,0,0,1
208,Nanoparticle triggered regulated necrosis WP2513,0.5734360175940056,1.250079744816587,0.6951804885841268,['FTL'],0.9991134529153675,0,0,1
209,Osteoclast Signaling WP12,0.5734360175940056,1.250079744816587,0.6951804885841268,['ATP6V1G1'],0.9991134529153675,0,0,1
210,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5734360175940056,1.250079744816587,0.6951804885841268,['RNASEL'],0.9991134529153675,0,0,1
211,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5734360175940056,1.250079744816587,0.6951804885841268,['ANAPC11'],0.9991134529153675,0,0,1
212,Breast cancer pathway WP4262,0.5771335937930512,0.9779676635670604,0.537570739663898,"['CCND1', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.9991134529153675,0,0,8
213,BDNF-TrkB Signaling WP3676,0.5944192544013154,1.022640195053988,0.5319471522607571,"['KRAS', 'HRAS']",0.9991134529153675,0,0,2
214,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5944192544013154,1.022640195053988,0.5319471522607571,"['KRAS', 'HRAS']",0.9991134529153675,0,0,2
215,p38 MAPK Signaling Pathway WP400,0.5944192544013154,1.022640195053988,0.5319471522607571,"['DDIT3', 'HRAS']",0.9991134529153675,0,0,2
216,ERK Pathway in Huntington's Disease WP3853,0.608288750240915,1.1249760765550239,0.5592318980655522,['HRAS'],0.9991134529153675,0,0,1
217,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.608288750240915,1.1249760765550239,0.5592318980655522,['CCND1'],0.9991134529153675,0,0,1
218,Genes targeted by miRNAs in adipocytes WP1992,0.608288750240915,1.1249760765550239,0.5592318980655522,['TMSB4X'],0.9991134529153675,0,0,1
219,Hedgehog Signaling Pathway Netpath WP47,0.608288750240915,1.1249760765550239,0.5592318980655522,['SAP18'],0.9991134529153675,0,0,1
220,NOTCH1 regulation of endothelial cell calcification WP3413,0.608288750240915,1.1249760765550239,0.5592318980655522,['DLL3'],0.9991134529153675,0,0,1
221,Purine metabolism and related disorders WP4224,0.608288750240915,1.1249760765550239,0.5592318980655522,['APRT'],0.9991134529153675,0,0,1
222,Transcriptional cascade regulating adipogenesis WP4211,0.608288750240915,1.1249760765550239,0.5592318980655522,['DDIT3'],0.9991134529153675,0,0,1
223,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6098724265503612,0.9640597178468703,0.47673281399455153,"['IFI27L2', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
224,IL-5 signaling pathway WP127,0.6169995715871934,0.9780942861902382,0.4723089661085611,"['RPS6', 'KRAS']",0.9991134529153675,0,0,2
225,Airway smooth muscle cell contraction WP4962,0.6402963032823245,1.0226185297955632,0.4559081246521689,['CALM2'],0.9991134529153675,0,0,1
226,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6402963032823245,1.0226185297955632,0.4559081246521689,['GOT1'],0.9991134529153675,0,0,1
227,TGF-beta Signaling Pathway WP366,0.6443185745083435,0.9150121986704568,0.40220458683671695,"['PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'SKP1', 'RBX1']",0.9991134529153675,0,0,7
228,p53 transcriptional gene network WP4963,0.6450097367457971,0.9117929050814957,0.39981194928900965,"['SIVA1', 'GADD45A', 'BAX']",0.9991134529153675,0,0,3
229,Head and Neck Squamous Cell Carcinoma WP4674,0.6530207008206721,0.8995009596928982,0.38331913993925704,"['CCND1', 'RPS6', 'KRAS', 'HRAS']",0.9991134529153675,0,0,4
230,Retinoblastoma gene in cancer WP2446,0.6530207008206721,0.8995009596928982,0.38331913993925704,"['CCNB1', 'CCND1', 'H2AFZ', 'RPA2']",0.9991134529153675,0,0,4
231,Hepatitis B infection WP4666,0.6555103876765321,0.9044173774517938,0.3819726562374424,"['YWHAQ', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9991134529153675,0,0,7
232,Common Pathways Underlying Drug Addiction WP2636,0.6592308433692096,0.8996934865900383,0.37488564267959823,"['CALM2', 'ACTG1']",0.9991134529153675,0,0,2
233,Regulation of Microtubule Cytoskeleton WP2038,0.6592308433692096,0.8996934865900383,0.37488564267959823,"['PARD6A', 'CFL2']",0.9991134529153675,0,0,2
234,Pathways in clear cell renal cell carcinoma WP4018,0.6612824695037458,0.8922281688852294,0.36900254562867957,"['LDHA', 'TPI1', 'PGK1', 'SQSTM1', 'PFKM']",0.9991134529153675,0,0,5
235,Hippo-Yap signaling pathway WP4537,0.6696907366446319,0.9373205741626794,0.3758086176301456,['YWHAQ'],0.9991134529153675,0,0,1
236,miRNAs involved in DNA damage response WP1545,0.6696907366446319,0.9373205741626794,0.3758086176301456,['CCND1'],0.9991134529153675,0,0,1
237,Overview of nanoparticle effects WP3287,0.6696907366446319,0.9373205741626794,0.3758086176301456,['BAX'],0.9991134529153675,0,0,1
238,Vitamin D in inflammatory diseases WP4482,0.6696907366446319,0.9373205741626794,0.3758086176301456,['IKBKG'],0.9991134529153675,0,0,1
239,PDGF Pathway WP2526,0.6789053836348102,0.865016209843796,0.3349978618624926,"['ARFIP2', 'HRAS']",0.9991134529153675,0,0,2
240,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6789053836348102,0.865016209843796,0.3349978618624926,"['CCND1', 'BAX']",0.9991134529153675,0,0,2
241,Apoptosis Modulation by HSP70 WP384,0.6966851995247112,0.8651453809348546,0.31268224585411153,['CYCS'],0.9991134529153675,0,0,1
242,Cannabinoid receptor signaling WP3869,0.6966851995247112,0.8651453809348546,0.31268224585411153,['PRKAR1A'],0.9991134529153675,0,0,1
243,Glycerolipids and Glycerophospholipids WP4722,0.6966851995247112,0.8651453809348546,0.31268224585411153,['CDIPT'],0.9991134529153675,0,0,1
244,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6966851995247112,0.8651453809348546,0.31268224585411153,['CCND1'],0.9991134529153675,0,0,1
245,MAPK pathway in congenital thyroid cancer WP4928,0.6966851995247112,0.8651453809348546,0.31268224585411153,['KRAS'],0.9991134529153675,0,0,1
246,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6966851995247112,0.8651453809348546,0.31268224585411153,['IKBKG'],0.9991134529153675,0,0,1
247,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6966851995247112,0.8651453809348546,0.31268224585411153,['CALM2'],0.9991134529153675,0,0,1
248,Rett syndrome causing genes WP4312,0.6976423879219048,0.832907620263942,0.2998872606947315,"['IMPDH2', 'GPS2']",0.9991134529153675,0,0,2
249,NRF2 pathway WP2884,0.713791766830081,0.8427403846153846,0.28414172095468054,"['FTH1', 'MGST3', 'PRDX1', 'TXN', 'SQSTM1', 'FTL']",0.9991134529153675,0,0,6
250,One-carbon metabolism and related pathways WP3940,0.7154636474879918,0.8030925013683634,0.2688950359254225,"['GPX4', 'SOD1']",0.9991134529153675,0,0,2
251,Ebstein-Barr virus LMP1 signaling WP262,0.7214754699682764,0.803280929596719,0.262236602108594,['IKBKG'],0.9991134529153675,0,0,1
252,Glycerophospholipid Biosynthetic Pathway WP2533,0.7214754699682764,0.803280929596719,0.262236602108594,['CDIPT'],0.9991134529153675,0,0,1
253,Pregnane X receptor pathway WP2876,0.7214754699682764,0.803280929596719,0.262236602108594,['PSMC5'],0.9991134529153675,0,0,1
254,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7214754699682764,0.803280929596719,0.262236602108594,['BAX'],0.9991134529153675,0,0,1
255,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7214754699682764,0.803280929596719,0.262236602108594,['CCND1'],0.9991134529153675,0,0,1
256,Oncostatin M Signaling Pathway WP2374,0.7366353143363681,0.7841646413520926,0.23968959433444,"['RPS6', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
257,Calcium Regulation in the Cardiac Cell WP536,0.7371098650413062,0.8276885669418975,0.2524601822059764,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CALM3', 'CALM2', 'YWHAH']",0.9991134529153675,0,0,7
258,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7442413695951807,0.7496650717703349,0.22144347203958348,['RPS6'],0.9991134529153675,0,0,1
259,Imatinib and Chronic Myeloid Leukemia WP3640,0.7442413695951807,0.7496650717703349,0.22144347203958348,['GADD45A'],0.9991134529153675,0,0,1
260,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7442413695951807,0.7496650717703349,0.22144347203958348,['CCND1'],0.9991134529153675,0,0,1
261,TLR4 Signaling and Tolerance WP3851,0.7442413695951807,0.7496650717703349,0.22144347203958348,['IKBKG'],0.9991134529153675,0,0,1
262,Urea cycle and metabolism of amino groups WP497,0.7442413695951807,0.7496650717703349,0.22144347203958348,['ODC1'],0.9991134529153675,0,0,1
263,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7447323840019746,0.7885645014647944,0.23241388460715487,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9991134529153675,0,0,4
264,Interleukin-11 Signaling Pathway WP2332,0.748458972040866,0.7494252873563219,0.21713765104451083,"['RPS6', 'HRAS']",0.9991134529153675,0,0,2
265,Thermogenesis WP4321,0.7561908449099405,0.7749023760672447,0.21655537595488772,"['RPS6', 'KRAS', 'HRAS', 'ACTG1']",0.9991134529153675,0,0,4
266,miRNAs involvement in the immune response in sepsis WP4329,0.7651480628172955,0.7027511961722488,0.18811659887397877,['IKBKG'],0.9991134529153675,0,0,1
267,NRF2-ARE regulation WP4357,0.7651480628172955,0.7027511961722488,0.18811659887397877,['RBX1'],0.9991134529153675,0,0,1
268,PDGFR-beta pathway WP3972,0.7651480628172955,0.7027511961722488,0.18811659887397877,['HRAS'],0.9991134529153675,0,0,1
269,Physiological and pathological hypertrophy of the heart WP1528,0.7651480628172955,0.7027511961722488,0.18811659887397877,['CALM2'],0.9991134529153675,0,0,1
270,Urea cycle and associated pathways WP4595,0.7651480628172955,0.7027511961722488,0.18811659887397877,['GOT1'],0.9991134529153675,0,0,1
271,Integrated Cancer Pathway WP1971,0.7781095436869055,0.7024664750957854,0.1762403830555963,"['BAD', 'BAX']",0.9991134529153675,0,0,2
272,Notch Signaling WP268,0.7781095436869055,0.7024664750957854,0.1762403830555963,"['NOTCH4', 'DLL3']",0.9991134529153675,0,0,2
273,Fragile X Syndrome  WP4549,0.7833312158615732,0.7588856868395774,0.1853196294910624,"['PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.9991134529153675,0,0,5
274,Spinal Cord Injury WP2431,0.7833312158615732,0.7588856868395774,0.1853196294910624,"['BCAN', 'GAP43', 'CCND1', 'GADD45A', 'APEX1']",0.9991134529153675,0,0,5
275,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7843472502544415,0.6613566000562905,0.1606457902108597,['H3F3B'],0.9991134529153675,0,0,1
276,MTHFR deficiency WP4288,0.7843472502544415,0.6613566000562905,0.1606457902108597,['CYCS'],0.9991134529153675,0,0,1
277,Metapathway biotransformation Phase I and II WP702,0.7897615826254795,0.7656031468531469,0.18070084974685455,"['AKR7A2', 'AKR7A3', 'GPX4', 'GSTO1', 'MGST3', 'SULT4A1']",0.9991134529153675,0,0,6
278,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.791754284644896,0.6811215604319053,0.15904473278713638,"['KRAS', 'HRAS']",0.9991134529153675,0,0,2
279,Gastrin signaling pathway WP4659,0.8013831932745169,0.7387886141867638,0.16357965873764246,"['CCND1', 'BAD', 'RPS6', 'KRAS', 'HRAS']",0.9991134529153675,0,0,5
280,Ethanol effects on histone modifications WP3996,0.8019782657894066,0.624561403508772,0.13782432044314286,['AHCY'],0.9991134529153675,0,0,1
281,One-carbon metabolism WP241,0.8019782657894066,0.624561403508772,0.13782432044314286,['AHCY'],0.9991134529153675,0,0,1
282,Toll-like Receptor Signaling related to MyD88 WP3858,0.8019782657894066,0.624561403508772,0.13782432044314286,['IKBKG'],0.9991134529153675,0,0,1
283,Trans-sulfuration and one-carbon metabolism WP2525,0.8019782657894066,0.624561403508772,0.13782432044314286,['AHCY'],0.9991134529153675,0,0,1
284,Tumor suppressor activity of SMARCB1 WP4204,0.8019782657894066,0.624561403508772,0.13782432044314286,['H3F3B'],0.9991134529153675,0,0,1
285,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8019782657894066,0.624561403508772,0.13782432044314286,['PPIB'],0.9991134529153675,0,0,1
286,White fat cell differentiation WP4149,0.8019782657894066,0.624561403508772,0.13782432044314286,['DDIT3'],0.9991134529153675,0,0,1
287,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8168354169879285,0.6420908593322386,0.12990631529446658,"['NABP2', 'BAX']",0.9991134529153675,0,0,2
288,Interferon type I signaling pathways WP585,0.8168354169879285,0.6420908593322386,0.12990631529446658,"['RPS6', 'RACK1']",0.9991134529153675,0,0,2
289,Estrogen signaling pathway WP712,0.818169083476741,0.5916393855452027,0.118733895685594,['IKBKG'],0.9991134529153675,0,0,1
290,Fluoropyrimidine Activity WP1601,0.818169083476741,0.5916393855452027,0.118733895685594,['GGH'],0.9991134529153675,0,0,1
291,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.818169083476741,0.5916393855452027,0.118733895685594,['IKBKG'],0.9991134529153675,0,0,1
292,Resistin as a regulator of inflammation WP4481,0.818169083476741,0.5916393855452027,0.118733895685594,['IKBKG'],0.9991134529153675,0,0,1
293,Type II interferon signaling (IFNG) WP619,0.818169083476741,0.5916393855452027,0.118733895685594,['HLA-B'],0.9991134529153675,0,0,1
294,Integrin-mediated Cell Adhesion WP185,0.8255064437915774,0.6910379447807471,0.13251219914446194,"['RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9991134529153675,0,0,4
295,IL-1 signaling pathway WP195,0.8283333391104023,0.6242017879948915,0.11756192889330919,"['IKBKG', 'SQSTM1']",0.9991134529153675,0,0,2
296,Heart Development WP1591,0.8330372428512852,0.5620095693779904,0.10266618192689622,['VEGFB'],0.9991134529153675,0,0,1
297,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8330372428512852,0.5620095693779904,0.10266618192689622,['GABRB3'],0.9991134529153675,0,0,1
298,Oxidative Stress WP408,0.8330372428512852,0.5620095693779904,0.10266618192689622,['SOD1'],0.9991134529153675,0,0,1
299,The influence of laminopathies on Wnt signaling WP4844,0.8330372428512852,0.5620095693779904,0.10266618192689622,['CCND1'],0.9991134529153675,0,0,1
300,Glioblastoma signaling pathways WP2261,0.8377308410590992,0.6479460137178258,0.11472429882521971,"['CCND1', 'KRAS', 'HRAS']",0.9991134529153675,0,0,3
301,IL17 signaling pathway WP2112,0.8466906991831211,0.5352016404647983,0.08906816237102322,['IKBKG'],0.9991134529153675,0,0,1
302,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8466906991831211,0.5352016404647983,0.08906816237102322,['YWHAQ'],0.9991134529153675,0,0,1
303,Zinc homeostasis WP3529,0.8466906991831211,0.5352016404647983,0.08906816237102322,['MT3'],0.9991134529153675,0,0,1
304,Cardiac Hypertrophic Response WP2795,0.8493962113233031,0.5912482355313571,0.09650916659014315,"['IKBKG', 'CALM2']",0.9991134529153675,0,0,2
305,RANKL/RANK signaling pathway WP2018,0.8590207876374509,0.5760389036251106,0.08753611458724121,"['IKBKG', 'SQSTM1']",0.9991134529153675,0,0,2
306,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8592286042338713,0.5108307959982601,0.07750338326680743,['CCND1'],0.9991134529153675,0,0,1
307,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8592286042338713,0.5108307959982601,0.07750338326680743,['HRAS'],0.9991134529153675,0,0,1
308,Target Of Rapamycin (TOR) Signaling WP1471,0.8592286042338713,0.5108307959982601,0.07750338326680743,['IDI1'],0.9991134529153675,0,0,1
309,Corticotropin-releasing hormone signaling pathway WP2355,0.8630423406541953,0.6124466137888956,0.09020819690837883,"['POMC', 'STAR', 'CRH']",0.9991134529153675,0,0,3
310,Phosphodiesterases in neuronal function WP4222,0.8680795198180172,0.5615900383141762,0.07944924109180913,"['PDE1C', 'PDE6G']",0.9991134529153675,0,0,2
311,Complement system WP2806,0.8706735014323471,0.6014587042870839,0.08329494971934728,"['RPS19', 'CD59', 'TXN']",0.9991134529153675,0,0,3
312,Cardiac Progenitor Differentiation WP2406,0.8707420234415222,0.4885791553983774,0.06762401143209996,['MESP1'],0.9991134529153675,0,0,1
313,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8707420234415222,0.4885791553983774,0.06762401143209996,['IKBKG'],0.9991134529153675,0,0,1
314,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8707420234415222,0.4885791553983774,0.06762401143209996,['DDIT3'],0.9991134529153675,0,0,1
315,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8707420234415222,0.4885791553983774,0.06762401143209996,['SUPT4H1'],0.9991134529153675,0,0,1
316,Melatonin metabolism and effects WP3298,0.8707420234415222,0.4885791553983774,0.06762401143209996,['CALM2'],0.9991134529153675,0,0,1
317,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8707420234415222,0.4885791553983774,0.06762401143209996,['BAX'],0.9991134529153675,0,0,1
318,Vitamin D-sensitive calcium signaling in depression WP4698,0.8707420234415222,0.4885791553983774,0.06762401143209996,['GPX4'],0.9991134529153675,0,0,1
319,Prolactin Signaling Pathway WP2037,0.8779264101977983,0.5908563354695463,0.07692506589241833,"['RPS6', 'PPIB', 'HRAS']",0.9991134529153675,0,0,3
320,Circadian rhythm related genes WP3594,0.8791237109304191,0.6825710340210068,0.08793538786684085,"['AHCY', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1']",0.9991134529153675,0,0,7
321,Mesodermal commitment pathway WP2857,0.8802626393149696,0.6447712743052105,0.08223088014215879,"['TRIM71', 'CCND1', 'PRKAR1A', 'NABP2', 'RPL38']",0.9991134529153675,0,0,5
322,Microglia Pathogen Phagocytosis Pathway WP3937,0.8813145948683764,0.4681818181818182,0.0591503851147746,['RAC3'],0.9991134529153675,0,0,1
323,AGE/RAGE pathway WP2324,0.8846111752980985,0.5347564313081554,0.06556492480114458,"['CYCS', 'SOD1']",0.9991134529153675,0,0,2
324,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8858916188771154,0.6373897476202952,0.07722656389053963,"['NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'DLL3']",0.9991134529153675,0,0,5
325,Nuclear Receptors Meta-Pathway WP2882,0.8865773445329954,0.7206542927366726,0.08675734362316316,"['PSMC5', 'CCND1', 'FTH1', 'MGST3', 'PRDX1', 'AIP', 'BAX', 'DBI', 'TXN', 'SQSTM1', 'FTL']",0.9991134529153675,0,0,11
326,Focal Adhesion WP306,0.8894996119410491,0.6845224962861639,0.08015498870350508,"['CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9991134529153675,0,0,8
327,Hedgehog Signaling Pathway WP4249,0.89102313448974,0.4494162679425837,0.05185584538844623,['CCND1'],0.9991134529153675,0,0,1
328,Neovascularisation processes WP4331,0.89102313448974,0.4494162679425837,0.05185584538844623,['NOTCH4'],0.9991134529153675,0,0,1
329,Neural Crest Cell Migration during Development WP4564,0.89102313448974,0.4494162679425837,0.05185584538844623,['PAK4'],0.9991134529153675,0,0,1
330,Insulin Signaling WP481,0.8942938742318872,0.6469304733727811,0.07227561554742551,"['CAP1', 'XBP1', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9991134529153675,0,0,6
331,EGF/EGFR signaling pathway WP437,0.8990216636982041,0.6407142857142857,0.06820284863090517,"['NDUFA13', 'AP2S1', 'NEDD8', 'KRAS', 'HRAS', 'AP2M1']",0.9991134529153675,0,0,6
332,Endochondral Ossification with Skeletal Dysplasias WP4808,0.899206137763895,0.5103622431208638,0.05422240255758468,"['HMGCS1', 'CALM2']",0.9991134529153675,0,0,2
333,Endochondral Ossification WP474,0.899206137763895,0.5103622431208638,0.05422240255758468,"['HMGCS1', 'CALM2']",0.9991134529153675,0,0,2
334,Alpha 6 Beta 4 signaling pathway WP244,0.9081245621927019,0.4160552897395003,0.04009679880956072,['HRAS'],0.9991134529153675,0,0,1
335,Neural Crest Cell Migration in Cancer WP4565,0.9081245621927019,0.4160552897395003,0.04009679880956072,['PAK4'],0.9991134529153675,0,0,1
336,Pre-implantation embryo WP3527,0.9081245621927019,0.4160552897395003,0.04009679880956072,['DDIT3'],0.9991134529153675,0,0,1
337,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9156417525586851,0.401161995898838,0.03535444305758269,['MAP1LC3A'],0.9991134529153675,0,0,1
338,IL-6 signaling pathway WP364,0.9156417525586851,0.401161995898838,0.03535444305758269,['BAD'],0.9991134529153675,0,0,1
339,Ebola Virus Pathway on Host WP4217,0.9157222363821991,0.5678952355499405,0.04999874345616662,"['CLTC', 'HLA-B', 'EIF2S1', 'ACTG1']",0.9991134529153675,0,0,4
340,Prostaglandin Synthesis and Regulation WP98,0.922544415956911,0.3872958257713249,0.03122369530182787,['S100A6'],0.9991134529153675,0,0,1
341,ATM Signaling Network in Development and Disease  WP3878,0.9288827454091243,0.37435406698564594,0.0276171342569434,['IKBKG'],0.9991134529153675,0,0,1
342,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9288827454091243,0.37435406698564594,0.0276171342569434,['RPS6'],0.9991134529153675,0,0,1
343,Vitamin B12 metabolism WP1533,0.9288827454091243,0.37435406698564594,0.0276171342569434,['SOD1'],0.9991134529153675,0,0,1
344,Endoderm differentiation WP2853,0.9323734656173861,0.5403417894225655,0.03783572112578756,"['TRIM71', 'TCEAL2', 'NABP2', 'NME1']",0.9991134529153675,0,0,4
345,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9342008455622071,0.5660349896661135,0.038526506930791515,"['YWHAQ', 'PRKAR1A', 'SLC25A4', 'VAMP2', 'YWHAH']",0.9991134529153675,0,0,5
346,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9347028377998403,0.36224726037968824,0.024461333367223084,['NUP98'],0.9991134529153675,0,0,1
347,Chemokine signaling pathway WP3929,0.9395295510876568,0.5275375409280795,0.03290568511627139,"['GNG3', 'KRAS', 'IKBKG', 'HRAS']",0.9991134529153675,0,0,4
348,Development of ureteric collection system WP5053,0.9400470280927523,0.3508971291866029,0.021694346627732015,['CCND1'],0.9991134529153675,0,0,1
349,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9400470280927523,0.3508971291866029,0.021694346627732015,['CCND1'],0.9991134529153675,0,0,1
350,Netrin-UNC5B signaling pathway WP4747,0.9400470280927523,0.3508971291866029,0.021694346627732015,['DAPK1'],0.9991134529153675,0,0,1
351,DNA IR-damage and cellular response via ATR WP4016,0.9419996464752413,0.43155025051576773,0.025785291326877152,"['RPA2', 'IKBKG']",0.9991134529153675,0,0,2
352,T-cell receptor (TCR) signaling pathway WP69,0.9419996464752413,0.43155025051576773,0.025785291326877152,"['IKBKG', 'HRAS']",0.9991134529153675,0,0,2
353,Phosphoinositides metabolism WP4971,0.9449541958912057,0.3402348847324924,0.0192636985876339,['PIP4P1'],0.9991134529153675,0,0,1
354,TGF-beta Receptor Signaling WP560,0.9494600472033811,0.3301998311286237,0.01712476662858243,['HRAS'],0.9991134529153675,0,0,1
355,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9496138463219288,0.4154959557258408,0.021481080488694196,"['IKBKG', 'CALM2']",0.9991134529153675,0,0,2
356,Complement and Coagulation Cascades WP558,0.9535973734748506,0.32073820915926177,0.015239470916073364,['CLTC'],0.9991134529153675,0,0,1
357,IL-4 signaling pathway WP395,0.9535973734748506,0.32073820915926177,0.015239470916073364,['BAD'],0.9991134529153675,0,0,1
358,Wnt Signaling Pathway WP363,0.9535973734748506,0.32073820915926177,0.015239470916073364,['CCND1'],0.9991134529153675,0,0,1
359,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9573962890084252,0.3118022328548644,0.013575207619459162,['RPS6'],0.9991134529153675,0,0,1
360,Adipogenesis WP236,0.959163860023373,0.44836049856184085,0.018693652620873812,"['GADD45A', 'DDIT3', 'GTF3A']",0.9991134529153675,0,0,3
361,Vitamin D Receptor Pathway WP2877,0.9594713973054114,0.48710673454059916,0.0201529568314465,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6']",0.9991134529153675,0,0,4
362,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9608844495175615,0.3033492822966507,0.012103975228226739,['HRAS'],0.9991134529153675,0,0,1
363,Neural Crest Differentiation WP2064,0.9620766368427162,0.38670894437838554,0.014950619238244384,"['NOTCH4', 'DLL3']",0.9991134529153675,0,0,2
364,Regulation of toll-like receptor signaling pathway WP1449,0.9662726926255035,0.4310052363743639,0.0147874423143906,"['CUEDC2', 'IKBKG', 'SQSTM1']",0.9991134529153675,0,0,3
365,B Cell Receptor Signaling Pathway WP23,0.9694215231405193,0.3675962565165505,0.011415978648715755,"['IKBKG', 'HRAS']",0.9991134529153675,0,0,2
366,3q29 copy number variation syndrome WP4906,0.9697281765316877,0.2805263157894737,0.008623232270335868,['DYNLL1'],0.9991134529153675,0,0,1
367,Allograft Rejection WP2328,0.9697281765316877,0.2805263157894737,0.008623232270335868,['HLA-B'],0.9991134529153675,0,0,1
368,MECP2 and Associated Rett Syndrome WP3584,0.9697281765316877,0.2805263157894737,0.008623232270335868,['RPS6'],0.9991134529153675,0,0,1
369,Pathways affected in adenoid cystic carcinoma WP3651,0.9722073862416447,0.27366087057999766,0.007713442775713742,['HRAS'],0.9991134529153675,0,0,1
370,Ectoderm Differentiation WP2858,0.9785849517159254,0.395273814223676,0.008556760095979617,"['KCNK10', 'CELSR2', 'LY6E']",0.9991134529153675,0,0,3
371,Genes related to primary cilium development (based on CRISPR) WP4536,0.9802173615233363,0.3345056327557614,0.006683735117284871,"['TRAF3IP1', 'DYNLL1']",0.9991134529153675,0,0,2
372,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9802546206476251,0.24925039872408294,0.004970781777850351,['CCND1'],0.9991134529153675,0,0,1
373,AMP-activated protein kinase (AMPK) signaling WP1403,0.9833575335029093,0.2386032780209712,0.004004361488370475,['CCNB1'],0.9991134529153675,0,0,1
374,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9840892885370142,0.531615925058548,0.008526399451033966,"['GNG3', 'RAB14', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'IKBKG', 'ITGAE', 'HRAS']",0.9991134529153675,0,0,9
375,Osteoblast differentiation WP4787,0.9862998114693045,0.31114303959131545,0.004292187792552143,"['NOTCH4', 'DLL3']",0.9991134529153675,0,0,2
376,MAPK Signaling Pathway WP382,0.9873340935884625,0.48258653263465584,0.006151435372295998,"['RRAS', 'GADD45A', 'DDIT3', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9991134529153675,0,0,7
377,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.988177967905869,0.21981424148606812,0.0026141338319932124,['CCND1'],0.9991134529153675,0,0,1
378,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9891468747587716,0.21556864188443137,0.002352382033691727,['YWHAQ'],0.9991134529153675,0,0,1
379,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9900364237412677,0.21148325358851675,0.0021176970495807084,['ACTG1'],0.9991134529153675,0,0,1
380,"GPCRs, Other WP117",0.9900364237412677,0.21148325358851675,0.0021176970495807084,['CELSR2'],0.9991134529153675,0,0,1
381,PI3K-Akt signaling pathway WP4172,0.9911858625121454,0.49935951870349315,0.004420935569044837,"['GNG3', 'CCND1', 'BAD', 'RPS6', 'VEGFB', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS']",0.9991134529153675,0,0,9
382,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9918573537884495,0.28340365682137836,0.002317102239343919,"['CAP1', 'HRAS']",0.9991134529153675,0,0,2
383,Toll-like Receptor Signaling Pathway WP75,0.9922912512471626,0.20010252904989748,0.0015485163811731922,['IKBKG'],0.9991134529153675,0,0,1
384,Joubert Syndrome WP4656,0.9935033916504011,0.1931694439861409,0.0012590404116033153,['PDE6G'],0.9991134529153675,0,0,1
385,"GPCRs, Class A Rhodopsin-like WP455",0.9948120323388843,0.31639501438159157,0.0016457197740534625,"['MAS1', 'GPR22', 'APLNR']",0.9991134529153675,0,0,3
386,Wnt signaling pathway and pluripotency WP399,0.9949739278737518,0.18362224488195153,0.000925225724992198,['CCND1'],0.9991134529153675,0,0,1
387,Wnt signaling WP428,0.9961117009946235,0.17497009569377991,0.0006816621627152974,['CCND1'],0.9991134529153675,0,0,1
388,Pathways Regulating Hippo Signaling WP4540,0.9964305470546165,0.17226352594773647,0.0006159865728129621,['PRKAR1A'],0.9991134529153675,0,0,1
389,ESC Pluripotency Pathways WP3931,0.99819970082067,0.15328046142754145,0.00027619938434366174,['HRAS'],0.9991134529153675,0,0,1
390,Ciliopathies WP4803,0.9991134529153675,0.2554653707376695,0.0002265825325409689,"['TRAF3IP1', 'NEK2', 'CCNQ']",0.9991134529153675,0,0,3
